Vir Biotechnology Inc (VIR)

Fixed asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 73,109 78,618 72,140 56,343 46,679 51,681 427,211 397,246 1,580,474 2,368,441 2,099,722 2,316,395 1,087,060 277,605 175,080 67,363 67,245 67,315 67,364 1,181
Property, plant and equipment US$ in thousands — — — — — — 104,126 103,758 188,166 100,226 85,135 65,583 130,054 26,610 20,251 17,291 17,946 31,710 31,488 32,245
Fixed asset turnover — — — — — — 4.10 3.83 8.40 23.63 24.66 35.32 8.36 10.43 8.65 3.90 3.75 2.12 2.14 0.04

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $73,109K ÷ $—K
= —

The fixed asset turnover ratio for Vir Biotechnology Inc has shown significant fluctuations over the periods listed. The ratio measures how efficiently the company is generating revenue from its fixed assets. A higher turnover ratio indicates that the company is effectively utilizing its fixed assets to generate sales.

From March 2020 to June 2022, the fixed asset turnover ratio increased steadily from 0.04 to 24.66, peaking at 35.32 in March 2022. This sharp increase suggests that the company was able to generate significant revenue relative to its investment in fixed assets during this period.

However, from September 2022 to March 2024, the fixed asset turnover ratio declined significantly, dropping to 4.10 in June 2023 and then approaching 0 in the subsequent periods. This could indicate a decrease in revenue generated from fixed assets, possibly due to changes in the company's operations, asset base, or revenue streams.

The sudden drop in the ratio from June 2022 to March 2023 may raise concerns about the company's efficiency in utilizing its fixed assets. It would be important for stakeholders to further investigate the reasons behind this decline and assess the impact on the company's overall financial performance and operational efficiency.